Brief 15 minute presentations from companies developing peptide therapeutics and related technologies. This rapid and compressed format is designed for quick introduction between symposium participants to new technologies, and companies. Each presentation is structured to highlight the value of the technology or therapeutic being offered and the business strategy.
Christopher Murray
Distinguished Scientist
Sutro Biopharma
Craig Beattie
Chief Science Officer
CDG Therapeutics Inc.
Dinesh Patel
CEO & President
Protagonist Therapeutics Inc
Joe Audie
CSO
CMD Bioscience LLC
Justin Romanowski
Manager, Business Analytics
Unigene Laboratories, Inc
Pascal Deschatelets
COO
Apellis Pharmaceuticals, Inc.
Preclinical and Clinical Developments of Peptides in Metabolic Disease
Andrew Young
Head Endocrine Biology
Glaxo Smith Kline
Christina Rondinone
VP Research and Development
Medimmune
Wolfgang Glaesner
Chief Scientific Officer,AME
Eli Lilly and Co
Frank Tagliaferri
Vice President R&D
4P Therapeutics
Jean Lachowicz
Chief Scientific Officer
Angiochem
Peter Daddona
Chief Scientific Officer
Zosano Pharma
Volker Schellenberger
Chief Scientific Officer
Amunix
David Fry
Senior Research Leader
Hoffmann La-Roche
Hanspeter Michel
Senior Principal Scientist
Hoffmann-La Roche Inc.
Phil Dawson
Scientist
Scripps Institute
